Involvement of direct inhibition of NMDA receptors in the effects of σ- receptor ligands on glutamate neurotoxicity in vitro

European Journal of Pharmacology

Volumn 404, Issue 1-2, 2000, Pages 41-48

  Nishikawa, Hiroyuki ^a   Hashino, Asami ^a   Kume, Toshiaki ^a   Katsuki, Hiroshi ^a   Kaneko, Shuji ^a   Akaike, Akinori ^a  

^a Grad Sch Pharmaceutical Sci   (Japan)

Author keywords

Receptor; Cortical culture; Glutamate; Neurotoxicity; Phencyclidine site

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6,7 DICHLORO 2,3 QUINOXALINEDIONE; AMPHETAMINE DERIVATIVE; DIZOCILPINE; GLUTAMIC ACID; HALOPERIDOL; N (3 PHENYL 1 PROPYL) 1 PHENYL 2 AMINOPROPANE; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTOXYVERINE; PHENCYCLIDINE; PRASTERONE; PREGNENOLONE; PROGESTERONE; RIMCAZOLE; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; FETUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; GLUTAMIC ACID; HALOPERIDOL; LIGANDS; NEURONS; NEUROPROTECTIVE AGENTS; PHENAZOCINE; PROPYLAMINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER;

EID: 0034666549     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00595-1     Document Type: Article

References (42)

1. Akaike A., Tamura Y., Terada K., Nakata N. Regulation by neuroprotective factors of NMDA receptor mediated nitric oxide synthesis in the brain and retina. Prog. Brain Res. 103:1994;391-403.
2. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663:1994;237-243.
3. Bergeron R., de Montigny C., Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci. 16:1996;1193-1202.
4. Bresnick G.H. Excitotoxins: a possible new mechanism for the pathogenesis of ischemic retinal damage. Arch. Ophthalmol. 107:1989;339-341.
5. Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
6. Contreras P.C., Gray N.M., Ragan D.M., Lanthorn T.H. BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci. 51:1992;1145-1149.
7. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6368-6371.
8. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
9. DeCoster M.A., Klette K.L., Knight E.S., Tortella F.C. σ Receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671:1995;45-53.
10. Ferris C.D., Hirsch D.J., Brooks B.P., Snyder S.H. σ Receptors: from molecule to man. J. Neurochem. 57:1991;729-737.
11. Fletcher E.J., McDonald J.F. Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur. J. Pharmacol. 235:1993;291-295.
12. Glennon R.A., Battaglia G., Smith J.D. (-)-PPAP: a new and selective ligand for sigma binding sites. Pharmacol. Biochem. Behav. 37:1990;557-559.
13. Goldberg M.P., Viseskul V., Choi D.W. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia. J. Pharmacol. Exp. Ther. 245:1988;1081-1087.
14. 1-binding site. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8072-8077.
15. Itzhak Y., Stein I. Sigma binding sites in the brain: an emerging concept of multiple sites and their relevance for psychiatric disorders. Life Sci. 47:1990;1073-1081.
16. Kume T., Kouchiyama H., Kaneko S., Maeda T., Kaneko S., Akaike A., Shimohama S., Kihara T., Kimura J., Wada K., Koizumi S. BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Res. 756:1997;200-204.
17. Kume T., Kouchiyama H., Nishikawa H., Maeda T., Kaneko S., Akaike A., Noda N., Fujita T. Ether extract of fetal calf serum protects cultured rat cortical neurons against glutamate cytotoxicity. Jpn. J. Pharmacol. 73:1997;371-374.
18. Kume T., Nishikawa H., Tomioka H., Katsuki H., Akaike A., Kaneko S., Maeda T., Kihara T., Shimohama S. p75-mediated neuroprotection by NGF against glutamate cytotoxicity in cortical cultures. Brain Res. 852:2000;279-289.
19. 3H]-1-[1-(2-thienyl) cyclohexy] piperidine. J. Pharmacol. Exp. Ther. 238:1986;739-748.
20. Lockhart B.P., Soulard P., Benicourt C., Privat A., Junien J.-L. Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675:1995;110-120.
21. Lysko P.G., Feuerstein G. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: protection by SKF10,047. Neurosci. Lett. 120:1990;217-220.
22. Lysko P.G., Gagnon R.C., Yue T.-L., Gu J.-L., Feuerstein G. Neuroprotective effects of SKF10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 23:1992;414-419.
23. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
24. 1 receptor agonist. Eur. J. Pharmacol. 306:1996;271-279.
25. 25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 83:1998;413-428.
26. 3H]-norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3774-3778.
27. 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Neurochem. Int. 32:1998;337-343.
28. O'Neill M., Caldwell M., Early B., Canney M., O'Halloran A., Kelly J., Leonard B.E., Junien J.-L. The σ receptor ligand JO1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischemia. Eur. J. Pharmacol. 283:1995;217-225.
29. 1 receptor. J. Neurochem. 70:1998;2279-2285.
30. Prasad P.D., Li H.W., Fei Y.-J., Ganapathy M.E., Fujita T., Plumley L.H., Yang-Feng T.L., Leibach F.H., Ganapathy V. Exon-intron structure, analysis of promotor region, and chromosomal localization of human type 1 σ receptor gene. J. Neurochem. 70:1998;443-451.
31. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur. J. Pharmacol. 315:1996;1-10.
32. 1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur. J. Pharmacol. 342:1998;105-111.
33. Seth P., Fei Y.-J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of a σ receptor from rat brain. J. Neurochem. 70:1998;922-931.
34. Steardo L., Monteleone P., d'Istria M., Serino I., Maj M., Cuomo V. (+)-N-Allylnormetazocine enhances N-acethyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland. J. Pharmacol. Exp. Ther. 275:1995;845-849.
35. Steardo L., Monteleone P., d'Istria M., Serino I., Maj M., Cuomo V. σ Receptor modulation of noradrenergic-stimulated pineal melatonin biosynthesis in rats. J. Neurochem. 67:1996;287-293.
36. Su T.-P., London E.D., Jaffe J.H. Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems. Science. 240:1988;219-221.
37. Takahashi H., Kirsch J.R., Hashimoto K., London E.D., Koehler R.C., Traystman R.J. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent σ-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke. 26:1995;1676-1682.
38. Takahashi H., Kirsch J.R., Hashimoto K., London E.D., Koehler R.C., Traystman R.J. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke. 27:1996;2120-2123.
39. Tamura Y., Sato Y., Akaike A., Shiomi H. Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 592:1994;317-325.
40. Tokuyama S., Hirata K., Ide A., Ueda H. Sigma ligands stimulate GTPase activity in mouse prefrontal membranes: evidence for the existence of metabotropic sigma receptor. Neurosci. Lett. 233:1997;141-144.
41. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., DeCosta B., Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 42:1990;355-402.
42. Whittemore E.R., Ilyin V.I., Woodward R.M. Antagonism of N-methyl-D-aspartate receptors by σ site ligands: potency, subtype-selectivity and mechanisms of inhibition. J. Pharmacol. Exp. Ther. 282:1997;326-338.